EUCTR2012-005115-13-ES进行中（未招募）不适用
A randomized, assessor-blinded, multicenter, international study investigating efficacy, patient's acceptance, safety and tolerability of Sodium Phosphate tablets compared to split dose Polyethylene Glycol for colon cleansing prior to colonoscopy.
ABORATOIRES MAYOLY SPINDLER0 个研究点目标入组 448 人开始时间: 2013年1月9日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 448
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •(1) Written informed consent form.
- •(2) Men and women aged from 18 to 75 years (included).
- •(3) Scheduled for a colonoscopy as an outpatient.
- •(4) Normal renal function (eGFR greater or equal to 60 mL/mn/1.73m2)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 224
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 224
排除标准
- •(1) Pregnant woman or likely to be (without contraception) or breast feeding.
- •(2) Having a disease or condition as follows:
- •- clinically significant abnormal electrolytes values (sodium, phosphate, potassium, calcium),
- •- primary hyperparathyroidism associated with hypercalcemia,
- •- congestive heart failure Class III and IV (Am. Heart Assoc., NYHA Classification),
- •- unstable angina pectoris or recent myocardial infarction, PTCA or coronary artery bypass surgery within previous 3 months
- •- ascites,
- •- known/suspected bowel obstruction, megacolon, ileus or intestinal perforation, or gastroparesis,
- •- inflammatory bowel disease,
- •- history of gastric stapling or bypass procedure or gastric retention
- •- history of colonic resection, except partial resection of the sigmoid
- •- severe chronic constipation (< 2 bowel movements per week)
- •- swallowing difficulties
- •- any other clinical condition which, in the opinion of the investigator, would not allow the subject to participate in the study in good conditions.
- •(3) Sodium phosphate preparation taken within the past three weeks prior to colonoscopy.
- •(4) Drugs that affect renal perfusion or function, including diuretics, angiotensin converting enzyme (ACE) inhibitors and angiotensin receptors blockers or daily use of non-steroidal anti-inflammatory drugs (NSAIDs) (occasional NSAIDs use is permitted) initiated within 4 weeks prior to first study drug intake,
- •(5) Concomitant use of medications known to prolong the QT interval.
- •(6) Known allergy to any of the active ingredients or excipients of the study drugs.
- •(7) History of phenylketonuria
- •(8) Subjects who have participated in a clinical trial in the previous 30 days.
- •(9) Subjects deprived of freedom by judicial or administrative decision, hospitalized without their consent or for other reasons than the research, under legal protection or unable to express their consent.
研究者
相似试验
招募中
不适用
A multicentre, assessor-blinded, randomized controlled trial to investigate the effectiveness of a blended intervention, focused on personal feedback and coaching regarding physical activity and protein intake, after discharge in patients who have undergone elective gastro-intestinal or lung cancer surgeryNL-OMON51948Vrije Universiteit Medisch Centrum161
招募中
Unknown
Optimal Physical Recovery After HospitalizatioNL-OMON24920Amsterdam Movement Sciences, Cancer Center Amsterdam161
已完成
3 期
A Phase III clinical trial of Teriparatide in postmenopausal women with osteoporosisCTRI/2021/04/032769Intas Pharmaceuticals Ltd
招募中
Unknown
A superiority, confirmatory clinical trial to assess the efficacy of cognitive therapy software ‘NDTx-01’ in patients with autism spectrum disorder (ASD) or social communication disorders (SCD)Mental and behavioural disordersKCT0009699eudive Inc.80
招募中
不适用
A multi-center, randomized, evaluator-blinded, prospective and comparative clinical trial to evaluate the efficacy and safety of the Lens Angle Supporter(LAS) for insertion of an intraocular lens in cataract surgery in cataract patientsKCT0007870osec33